瘤新抗原:用于癌症免疫治疗的新策略
Hanyang Guan1, Yue Wu2, L U Li3
1Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Oncology research
|July 7, 2023
概括
新抗原向免疫疗法提供了有前途的癌症治疗方法. 通过疫苗和细胞疗法利用瘤特异性新抗原,以及人工智能,将推进个性化癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 来自癌细胞突变的新抗原具有高度免疫性和瘤特异性,使其成为癌症免疫治疗的理想点.
- 新抗原向疗法正在快速发展,在癌症治疗的临床应用中显示出重大前景.
研究的目的:
- 审查新抗原疫苗和采用细胞疗法的最新临床进展.
- 讨论新抗原负荷作为癌症治疗中的预测生物标志物 (免疫检查点) 的潜力.
- 突出测序,生物信息学和人工智能在基于新抗原的个性化免疫治疗中的未来作用.
主要方法:
- 对新抗原疫苗 (例如树突细胞,核酸,类疫苗) 的临床试验和研究的文献综述.
- 使用新抗原 (例如瘤透性淋巴细胞,T细胞受体,仿真抗原受体) 的采用细胞疗法方法的审查.
- 对研究新抗原负担作为临床免疫检查点的研究进行分析.
主要成果:
- 新抗原疫苗和采用细胞疗法在临床环境中越来越多地用于癌症治疗.
- 新抗原负担显示出作为免疫疗法反应的预测标记物的潜力.
- 技术进步正在加强新抗原的识别和应用.
结论:
- 新抗原向免疫疗法,包括疫苗和细胞疗法,是一个快速发展的领域,具有显著的治疗潜力.
- 预计人工智能等先进技术的整合将充分释放新抗原在个性化癌症免疫治疗中的潜力.
- 进一步的研究和临床验证对于优化基于新抗原的治疗策略至关重要.
相关概念视频
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Cancer Vaccines
428
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
428
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


